FINWIRES · TerminalLIVE
FINWIRES

AIM ImmunoTech Says Pancreatic Cancer Drug Has Shown 'Positive Progress' in Phase 2 Study; Shares Rise Pre-Bell

By

AIM ImmunoTech (AIM) said Monday that its metastatic pancreatic cancer drug Ampligen has shown "positive progress" in an ongoing phase 2 study.

According to the company, the study is showing overall median survival of 34.8 months, compared with 12.5 months for historical controls in one group of study patients with a specific immune marker.

The specific indication for the trial is patients with stable disease after Folfirinox standard of care. The company said it remains on track for a planned December evaluation of the 25-patient trial's primary endpoint of clinical benefit rate at six months.

Shares of AIM rose more than 26% in recent premarket trading Monday.

Price: $0.6520, Change: $+0.135, Percent Change: +26.02%

Related Articles

Wire

Top Cryptocurrencies Fall; Bitcoin Drops Below $61,000 Level

Top cryptocurrencies fell Friday, with Bitcoin (BTC-USD) falling below the $61,000 level.The CoinDesk Market Index, which tracks dozens of digital assets including Bitcoin, fell almost 9.3% in the past 24 hours. The Nasdaq 100 dropped 4.5%, the S&P 500 declined 2.4%, and the Dow Jones Industrial Average fell 1.2%.Bitcoin fell 5.2% to $60,177, according to CoinMarketCap data. The most popular cryptocurrency's 24-hour trading volume declined 1.8% to $66.16 billion.Ethereum (ETH-USD), the second-largest digital asset by market value, fell 11.4% to $1,570.XRP (XRP-USD) dropped 6.4%, BNB (BNB-USD) fell 6.3%, and Solana (SOL-USD) shed 8.2%. Dogecoin (DOGE-USD) declined 8.5%, and Cardano (ADA-USD) lost 13.7%.The US 10-year Treasury yield stood at 4.534% at 3 p.m. ET Friday, up from 4.476% Thursday, while the five-year yield rose to 4.276% from 4.186%.The total market value of the cryptocurrency industry fell 5.8% in the past 24 hours to $2.05 trillion, with trading volume rising 2.6% to $158.92 billion.Price: $60361.64, Change: $-3450.54, Percent Change: -5.41%

$ADA-USD$BNB-USD$BTC-USD$DOGE-USD$ETH-USD$SOL-USD$XRP-USD
Wire

Cognizant Unveils AI Platform to Link Robots, Sensors, Industrial Systems

Cognizant Technology Solutions (CTSH) launched a new platform that uses artificial intelligence to control and coordinate systems including robots, sensors, and industrial equipment through a cloud-based service.The platform, built on the company's "Intelligence Spine" data-integration framework, is designed to help organizations link their physical infrastructure with AI tools more easily, Cognizant said Friday in a statement.The service will be available across sectors including utilities, oil and gas, manufacturing, logistics, aerospace, healthcare, and consumer and retail sectors, Cognizant said.The technology brings together capabilities such as computer vision, sensing, location tracking, and fast device-to-device communication, allowing businesses to automate tasks and direct physical operations with greater precision, the company said.Price: $53.06, Change: $-0.34, Percent Change: -0.64%

$CTSH
Wire

SpaceX Signs $920 Million Monthly Cloud Deal With Google

SpaceX has entered into a cloud services agreement with Alphabet's (GOOGL) Google, providing access to about 110,000 NVIDIA GPUs along with CPUs, memory and related components, the company said Friday.Under the agreement, Google will pay SpaceX $920 million per month from October 2026 through June 2029, with capacity ramping up through September at a reduced fee, SpaceX said.If SpaceX fails to deliver the committed GPU capacity by September 30, Google may terminate the agreement or accept a reduced allocation at a proportionally lower fee following a one-month grace period, the company said, adding that after December 31, 2026, either party may exit the deal with 90 days' notice.Price: $364.77, Change: $-7.42, Percent Change: -1.99%

$GOOGL$SPCX